CAPTRUST Financial Advisors
ADVM

CAPTRUST Financial Advisors’s Adverum Biotechnologies ADVM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$21.5K – 2624
2025
Q2 		$21.5K Sell
10,000
-624
-6% -$1.75K ﹤0.01% 2469
2025
Q1 		$46.4K Buy
+10,624
New +$47.9K ﹤0.01% 2287
2024
Q4 		– Sell
-10,115
Closed -$71K – 2294
2024
Q3 		$71K Buy
+10,115
New +$73.4K ﹤0.01% 2221
2023
Q4 		– Sell
-2,050
Closed -$30.8K – 2659
2023
Q3 		$30.8K Buy
+2,050
New +$36.8K ﹤0.01% 2507
2022
Q3 		– Sell
-50
Closed -$1K – 2094
2022
Q2 		$1K Hold
50
– – ﹤0.01% 4615
2022
Q1 		$1K Sell
50
-91
-65% -$1.33K ﹤0.01% 4643
2021
Q4 		$2K Buy
141
+38
+37% +$761 ﹤0.01% 4382
2021
Q3 		$2K Buy
103
+53
+106% +$1.35K ﹤0.01% 4223
2021
Q2 		$2K Hold
50
– – ﹤0.01% 4137
2021
Q1 		$5K Hold
50
– – ﹤0.01% 3708
2020
Q4 		$5K Hold
50
– – ﹤0.01% 2823
2020
Q3 		$5K Hold
50
– – ﹤0.01% 2510
2020
Q2 		$11K Buy
+50
New +$8.86K ﹤0.01% 2141

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

CAPTRUST Financial Advisors's ADVM Position: Q3 2025 in Review

CAPTRUST Financial Advisors sold out of Adverum Biotechnologies (ADVM) in Q3 2025, closing a stake of 10,000 shares — an estimated $21.5K sold.

CAPTRUST Financial Advisors first reported a position in ADVM in Q2 2020 and held it in 13 quarters. The position peaked at $71K in Q3 2024. 50 funds tracked by Wall St. Rank hold ADVM as of Q3 2025.

  • CAPTRUST Financial Advisors reported no remaining Adverum Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,000 Adverum Biotechnologies shares in Q3 2025, an estimated $21.5K.
  • CAPTRUST Financial Advisors first reported a position in Adverum Biotechnologies in Q2 2020 and held it in 13 quarters.
  • CAPTRUST Financial Advisors's Adverum Biotechnologies position peaked at $71K in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2025, filed 19 Nov 2025.